Building the Future of Medicine: Real Estate as a Biotech Catalyst

PASADENA, CA – June 30, 2026 – An unconventional force is shaping the future of medicine, and it’s not a pharmaceutical giant or a new biotech startup. It’s a real estate company. Alexandria Real Estate Equities, Inc. (NYSE: ARE), a pioneer in life science properties, today released its 2025 Corporate Responsibility Report, offering a detailed look into a business model where building design, community, and environmental stewardship are inseparable from scientific progress. The report argues that the very ground on which innovation occurs is a critical catalyst for discovery, a concept that redefines the role of infrastructure in solving humanity's most pressing health challenges.

For decades, real estate has been viewed as a container for commerce. But Alexandria’s report reframes it as a core component of the scientific enterprise itself. This perspective is particularly resonant today, as the life science industry navigates economic headwinds and regulatory shifts while confronting the staggering reality that over 90% of the world's 10,000 known diseases still lack approved treatments.

Beyond Bricks and Mortar: The Megacampus Ecosystem

At the heart of Alexandria's strategy is its signature “Megacampus™” concept. This is not simply a collection of office parks but a curated ecosystem designed to accelerate innovation. The company’s 100-acre Campus Point in San Diego serves as a prime example, bringing together industry titans like Eli Lilly and Novartis, government contractors like Leidos, and academic powerhouses like the University of California, San Diego. By clustering these entities in close proximity, the campus is engineered to foster what innovators call “serendipitous collisions”—the unplanned coffee-line conversations and hallway encounters that can spark groundbreaking ideas.

This model is more than an architectural theory; it's a proven engine for results. According to the company, nearly half of all novel therapies approved by the U.S. Food and Drug Administration since 2013 have been marketed by its tenants. This striking statistic suggests that the right environment—one rich with collaborative spaces, cutting-edge amenities, and a high density of intellectual capital—can tangibly shorten the timeline from lab bench to patient bedside. The company further deepens this ecosystem by providing strategic capital to transformative life science companies through its venture platform, acting as both landlord and strategic partner.

The ESG Edge: Where Responsibility Meets Return

While many companies treat corporate responsibility as a peripheral department, Alexandria’s report insists it is a core driver of its business. “Corporate responsibility at Alexandria is not a separate initiative; it is a strategic business imperative that is deeply integrated into how we operate, allocate capital and create long-term value,” stated Marc Binda, the company’s chief financial officer and treasurer.

This integration of Environmental, Social, and Governance (ESG) principles appears to be paying financial dividends. By building a reputation for integrity and mission-driven focus, the company has cultivated deep trust within the life science industry. This is validated by external accolades, including repeated recognition from Newsweek as “One of the World’s Most Trustworthy Companies.” In the world of high-stakes R&D, where partnerships can last for decades, trust is a currency as valuable as capital. This reputation, combined with best-in-class facilities, makes Alexandria’s properties highly attractive to top-tier tenants, leading to higher occupancy, longer lease terms, and greater long-term asset value.

This approach also enhances its appeal to a growing class of institutional investors who prioritize ESG performance. Consistent high marks from independent evaluators like GRESB signal a well-managed, lower-risk, and forward-thinking enterprise. Furthermore, being listed among the top companies for talent readiness by The Wall Street Journal underscores how a quality physical environment directly impacts a tenant’s ability to attract and retain the world-class scientists essential for success.

Sustainable Foundations for Scientific Breakthroughs

The report also highlights significant progress in environmental stewardship, a critical challenge for the energy-intensive life science sector. Alexandria reported a 16% reduction in its operational greenhouse gas (GHG) emissions intensity from 2022 levels and confirmed that renewable electricity now accounts for 32% of its total consumption. While these numbers are noteworthy on their own, they are particularly impressive given that modern laboratories are complex, 24/7 operations with heavy power demands for ventilation, cooling, and specialized equipment.

This commitment is validated by a ninth consecutive GRESB Green Star designation and a Best in Building Health Fitwel Innovation award. These certifications are not just plaques on a wall; they represent a dual commitment to planetary and human health. By developing highly efficient, sustainable buildings, Alexandria reduces its environmental footprint and operational costs. Simultaneously, by focusing on healthy building standards that improve air quality, access to natural light, and overall well-being, it creates environments where scientists can perform at their peak. This sustainable infrastructure provides a resilient foundation, allowing tenants to focus on their critical research without being burdened by operational or environmental liabilities.

Cultivating a Wider Ecosystem of Impact

Alexandria’s concept of an “ecosystem” extends far beyond the physical boundaries of its campuses. The company’s social impact initiatives demonstrate a commitment to advancing science and community health on multiple fronts. A key example is its leadership in a public-private partnership to develop a precision medicine framework for depression, an effort recognized with the Charles A. Sanders, MD, Partnership Award from the Foundation for the National Institutes of Health. This project aims to validate biomarkers that could lead to personalized treatments for a condition that affects millions.

Furthering its long-term vision, the company has also deepened its commitment to the future of science through educational initiatives like the ARE Learning Lab at the Fred Hutch Cancer Center in Seattle. By investing in STEM education, Alexandria is helping to cultivate the next generation of innovators who will one day populate its campuses. This holistic approach—fusing real estate development with venture capital, environmental stewardship, and community investment—presents a powerful model for how a mission-driven business can create value for shareholders while making a positive and lasting impact on the world.